C
Christina Schempp
Researcher at Ludwig Maximilian University of Munich
Publications - 3
Citations - 272
Christina Schempp is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Cancer & Metastasis. The author has an hindex of 3, co-authored 3 publications receiving 245 citations. Previous affiliations of Christina Schempp include Heidelberg University.
Papers
More filters
Journal ArticleDOI
Fighting Cancer with Red Wine? Molecular Mechanisms of Resveratrol
TL;DR: Although there has been remarkable evidence for resveratrol as a potent chemopreventive agent in vitro, it seems that the low bioavailability of resverAtrol in humans could interfere with a successful in vivo treatment, Nevertheless, resver atrol offers two major advantages over conventional chemotherapy.
Journal ArticleDOI
The V-ATPase-inhibitor Archazolid abrogates tumor metastasis via inhibition of endocytic activation of the Rho-GTPase Rac1
Romina M. Wiedmann,Karin von Schwarzenberg,Andrea Palamidessi,Laura Schreiner,Rebekka Kubisch,Johanna Liebl,Christina Schempp,Dirk Trauner,György Vereb,Stefan Zahler,Ernst Wagner,Rolf Müller,Giorgio Scita,Angelika M. Vollmar +13 more
TL;DR: The results indicate that archazolid effectively decreases metastatic dissemination of breast tumors by impairing the trafficking and spatially restricted activation of EGFR and Rho-GTPase Rac1, which are pivotal for directed movement of cells.
Journal ArticleDOI
V-ATPase Inhibition Regulates Anoikis Resistance and Metastasis of Cancer Cells
Christina Schempp,Karin von Schwarzenberg,Laura Schreiner,Rebekka Kubisch,Rolf Müller,Ernst Wagner,Angelika M. Vollmar +6 more
TL;DR: V-ATPase inhibition is not only an interesting option to reduce cancer metastasis, but also to better understand anoikis resistance and to find choices to fight against it.